Inherited gene variants may shape CAR-T therapy benefits and toxic side effects

Дата публикации: 24-07-2026 18:00:01

Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, the treatment can cause serious side effects. New research led by investigators at the Mass General Brigham Cancer Institute, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute has shown that patients' inherited genetic makeup can influence whether they benefit from CAR-T cell therapy or experience toxicity from the treatment. The results are published in Science Immunology.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tumors	0	8.11	12-08-2026
2	New personalised therapy targets chronic blood cancer	0	7.58	02-07-2026
3	Bessere Vorhersagbarkeit von Therapieergebnissen und Nebenwirkungen personalisierter Krebsimmuntherapien	0	11.69	11-12-2025
4	Autoantibodies could shape cancer risk, growth and response to immunotherapy	0	9.66	25-07-2026
5	Innovativer Ansatz zur Minimierung schwerer Nebenwirkungen nach Blutstammzelltransplantation erreicht wichtigen Meilenstein	0	9.9	27-01-2026
6	Redesigned lung cancer drug matches tumor control with fewer off-target interactions	0	9.72	24-07-2026
7	A More Precise CAR T-Cell Approach for DIPG and DMG	0	12.46	22-01-2026
8	Врач Паровичникова: инновационная терапия не заменит трансплантацию костного мозга	0	0	12-04-2025
9	Brain tumor vaccine links mutation targeting to eight-year survival gains	7	8	06-07-2026
10	Beyond the Petri dish: Testing tomorrow's drugs in human blood	0	7.95	27-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.44. Источник: medicalxpress.com.